Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pennant Group, Inc. Director's Dealing 2019

Oct 3, 2019

32342_dirs_2019-10-03_708ae2dd-c2f0-49f9-ae5d-71dc14da1d0c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pennant Group, Inc. (PNTG)
CIK: 0001766400
Period of Report: 2019-10-01

Reporting Person: Freeman Jennifer (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-01 Common Stock A 7141 $0.00 Acquired 7141 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-10-01 Stock Option (right to buy) $15.09 A 12000 Acquired 2029-10-01 Common Stock (12000) Direct

Footnotes

F1: Shares of Cornerstone Healthcare, Inc. converted into shares of The Pennant Group, Inc. (the "Registrant") pursuant to the merger of Cornerstone Merger Sub, Inc., a wholly-owned subsidiary of the Registrant, with and into Cornerstone Healthcare, Inc., with Cornerstone Healthcare, Inc. as the surviving corporation, in connection with the spin-off of the Registrant from The Ensign Group, Inc

F2: Options granted on October 1, 2019 under The Pennant Group, Inc. 2019 Omnibus Incentive Plan. The options vest in five equal annual installments beginning on the first anniversary of the date of the grant.